Most Recent

image: Ruth Nussenzweig, Malaria Researcher, Dies

Ruth Nussenzweig, Malaria Researcher, Dies

By Jim Daley | April 6, 2018

The microbiologist’s research led to the development of the first human malaria vaccine.

0 Comments

image: Robert Baker, Bat Biologist, Dies

Robert Baker, Bat Biologist, Dies

By Diana Kwon | April 5, 2018

The Texas Tech University professor also investigated the effects of the Chernobyl disaster on surrounding wildlife.

0 Comments

image: USDA Will Not Regulate CRISPR-Edited Crops

USDA Will Not Regulate CRISPR-Edited Crops

By Diana Kwon | April 2, 2018

Restrictions will remain on transgenic plants, which contain artificially inserted genes from other species.

0 Comments

Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.

0 Comments

image: Cancer Evolutionist: A Profile of Charles Swanton

Cancer Evolutionist: A Profile of Charles Swanton

By Anna Azvolinsky | April 1, 2018

Motivated by his father’s cancer diagnosis, the Francis Crick Institute cancer geneticist has been revealing the ways tumors evolve and why they are so difficult to treat.

0 Comments

In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.

0 Comments

Errors in segregation during cell division can lead to inflammation in daughter cells.

0 Comments

image: Genetic Mutation Linked to Cot Death

Genetic Mutation Linked to Cot Death

By Catherine Offord | March 29, 2018

Alterations to a protein involved in breathing may help explain some cases of sudden infant death syndrome, a study finds.

0 Comments

Last year, researchers claimed the gene-editing method had accuracy issues, but a new whole-genome sequencing analysis by the same team finds otherwise.

0 Comments

The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process